The Role of cccDNA in HBV Maintenance

Chronic hepatitis B virus (HBV) infection continues to be a major health burden worldwide; it can cause various degrees of liver damage and is strongly associated with the development of liver cirrhosis and hepatocellular carcinoma. The molecular mechanisms determining HBV persistence are not fully understood, but these appear to be multifactorial and the unique replication strategy employed by HBV enables its maintenance in infected hepatocytes. Both the stability of the HBV genome, which forms a stable minichromosome, the covalently closed circular DNA (cccDNA) in the hepatocyte nucleus, and the inability of the immune system to resolve chronic HBV infection are believed to be key mechanisms of HBV chronicity. Since a true cure of HBV requires clearance of intranuclear cccDNA from infected hepatocytes, understanding the mechanisms involved in cccDNA biogenesis, regulation and stability is mandatory to achieve HBV eradication. This review will summarize the state of knowledge on these mechanisms including the impact of current treatments on the cccDNA stability and activity. We will focus on events challenging cccDNA persistence in dividing hepatocytes.

[1]  F. Zoulim,et al.  Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B. , 2017, Journal of hepatology.

[2]  M. Nassal,et al.  A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation—and Beyond? , 2017, Viruses.

[3]  A. Lohse,et al.  Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo , 2017, Gut.

[4]  Jianming Hu,et al.  Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application , 2017, Viruses.

[5]  T. Volz,et al.  Serum HBV pgRNA as a clinical marker for cccDNA activity. , 2017, Journal of hepatology.

[6]  M. Manns,et al.  Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B. , 2016, The Journal of infectious diseases.

[7]  N. Xia,et al.  Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. , 2016, Journal of hepatology.

[8]  C. Delaugerre,et al.  Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. , 2016, Journal of hepatology.

[9]  Wenhui Li,et al.  DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus , 2016, PLoS pathogens.

[10]  Yanbao Yu,et al.  Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication. , 2016, Cell reports.

[11]  Xuan Wang,et al.  Asymmetric partitioning of transfected DNA during mammalian cell division , 2016, Proceedings of the National Academy of Sciences.

[12]  U. Protzer,et al.  Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure. , 2016, Journal of hepatology.

[13]  S. Fletcher,et al.  Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor , 2016, Nature.

[14]  M. Heikenwalder,et al.  Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. , 2016, Gastroenterology.

[15]  B. McMahon,et al.  Present and future therapies of hepatitis B: From discovery to cure , 2015, Hepatology.

[16]  L. Calvo,et al.  IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome , 2015, PloS one.

[17]  Meghan M. Holdorf,et al.  Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation , 2015, Proceedings of the National Academy of Sciences.

[18]  Y. Liaw,et al.  Systematic review: cessation of long‐term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B , 2015, Alimentary pharmacology & therapeutics.

[19]  K. Caldecott,et al.  Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair? , 2015, PloS one.

[20]  M. Nassal HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B , 2015, Gut.

[21]  R. Gish,et al.  Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. , 2015, World journal of gastroenterology.

[22]  B. Autran,et al.  Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure , 2015, Gut.

[23]  M. Heikenwalder,et al.  The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets , 2015, The Journal of pathology.

[24]  T. Berg,et al.  Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors , 2015, Hepatology.

[25]  A. Bertoletti,et al.  Circumventing failed antiviral immunity in chronic hepatitis B virus infection: triggering virus-specific or innate-like T cell response? , 2014, Medical Microbiology and Immunology.

[26]  J. Chen,et al.  Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg loss , 2014, Journal of viral hepatitis.

[27]  M. Nassal,et al.  Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses , 2014, Proceedings of the National Academy of Sciences.

[28]  T. Liang,et al.  Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA , 2014, Science.

[29]  A. Lohse,et al.  Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. , 2014, Journal of hepatology.

[30]  S. Litwin,et al.  Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. , 2013, Virology.

[31]  E. Giang,et al.  Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. , 2013, Journal of hepatology.

[32]  A. Lohse,et al.  The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. , 2013, Journal of hepatology.

[33]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[34]  D. Vassilopoulos,et al.  Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir. , 2012, Gastroenterology.

[35]  T. Block,et al.  Characterization of the Host Factors Required for Hepadnavirus Covalently Closed Circular (ccc) DNA Formation , 2012, PloS one.

[36]  A. Lohse,et al.  Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation , 2012, Hepatology.

[37]  M. Levrero,et al.  IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. , 2012, The Journal of clinical investigation.

[38]  A. Bertoletti,et al.  Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection , 2011, Postgraduate Medical Journal.

[39]  Fabien Zoulim,et al.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. , 2011, Journal of hepatology.

[40]  A. Lohse,et al.  Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. , 2011, Gastroenterology.

[41]  H. Blum,et al.  Generation of Covalently Closed Circular DNA of Hepatitis B Viruses via Intracellular Recycling Is Regulated in a Virus Specific Manner , 2010, PLoS pathogens.

[42]  U. Protzer,et al.  Control of hepatitis B virus at the level of transcription , 2010, Journal of viral hepatitis.

[43]  Jinhong Chang,et al.  Interferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus , 2010, Journal of Virology.

[44]  S. Litwin,et al.  Clonal Expansion of Normal-Appearing Human Hepatocytes during Chronic Hepatitis B Virus Infection , 2010, Journal of Virology.

[45]  Hildegard Büning,et al.  Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection , 2009, Hepatology.

[46]  M. Levrero,et al.  Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function , 2009, Proceedings of the National Academy of Sciences.

[47]  P. Klenerman,et al.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.

[48]  M. Levrero,et al.  Control of cccDNA function in hepatitis B virus infection. , 2009, Journal of hepatology.

[49]  S. Litwin,et al.  Detection of Clonally Expanded Hepatocytes in Chimpanzees with Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.

[50]  F. Zoulim,et al.  Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.

[51]  M. Nassal Hepatitis B viruses: reverse transcription a different way. , 2008, Virus research.

[52]  A. Quaas,et al.  Sequential Combination Therapy Leads to Biochemical and Histological Improvement Despite Low Ongoing Intrahepatic Hepatitis B virus Replication , 2008, Antiviral therapy.

[53]  S. Litwin,et al.  Hepatocyte turnover in transient and chronic hepadnavirus infections , 2007, Journal of viral hepatitis.

[54]  A. Cuconati,et al.  Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation , 2007, Journal of Virology.

[55]  A. Quaas,et al.  Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. , 2007, Gastroenterology.

[56]  M. Kann,et al.  Intracellular transport of hepatitis B virus. , 2007, World journal of gastroenterology.

[57]  J. Koskinas,et al.  Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients , 2006, Hepatology.

[58]  M. Kann,et al.  Lipid-Mediated Introduction of Hepatitis B Virus Capsids into Nonsusceptible Cells Allows Highly Efficient Replication and Facilitates the Study of Early Infection Events , 2006, Journal of Virology.

[59]  M. Levrero,et al.  Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. , 2006, Gastroenterology.

[60]  Junn-Liang Chang,et al.  Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. , 2006, Biochemical and biophysical research communications.

[61]  M. Yuen,et al.  One-Year Entecavir or Lamivudine Therapy Results in Reduction of Hepatitis B Virus Intrahepatic Covalently Closed Circular DNA Levels , 2005, Antiviral therapy.

[62]  M. Lutgehetmann,et al.  Temporary HBV Resolution in an HIV-Coinfected Patient during Hbv-Directed Combination Therapy Followed by Relapse of HBV , 2005, Antiviral therapy.

[63]  Bryan Boyd,et al.  Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  V. Wong,et al.  Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy. , 2005, Gastroenterology.

[65]  J. Summers,et al.  Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Gibbs,et al.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.

[67]  R. Purcell,et al.  Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  S. Litwin,et al.  Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[69]  F. Chisari,et al.  Transcriptional and posttranscriptional control of hepatitis B virus gene expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[71]  L. Wodicka,et al.  Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral Replication , 2002, Journal of Virology.

[73]  M. Manns,et al.  Structural organization of the hepatitis B virus minichromosome. , 2001, Journal of molecular biology.

[74]  F. Chisari,et al.  Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.

[75]  H. Will,et al.  Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir In vitro do not lead to reduction of the closed circular DNA , 2000, Hepatology.

[76]  F. Chisari,et al.  Intrahepatic Induction of Alpha/Beta Interferon Eliminates Viral RNA-Containing Capsids in Hepatitis B Virus Transgenic Mice , 2000, Journal of Virology.

[77]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[78]  H. O'brodovich,et al.  Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer , 1999, Gene Therapy.

[79]  W. Mason,et al.  Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus , 1997, Journal of virology.

[80]  F. Chisari Cytotoxic T cells and viral hepatitis. , 1997, The Journal of clinical investigation.

[81]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[82]  S. Locarnini,et al.  The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes , 1995, Journal of virology.